resveratrol has been researched along with Cardiovascular Diseases in 176 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (2.27) | 18.2507 |
| 2000's | 26 (14.77) | 29.6817 |
| 2010's | 118 (67.05) | 24.3611 |
| 2020's | 28 (15.91) | 2.80 |
| Authors | Studies |
|---|---|
| Kishore, N; Kumar, P; Shanker, K; Verma, AK | 1 |
| Deres, L; Gal, R; Habon, T; Halmosi, R; Toth, K | 1 |
| Abdelhaleem, IA; Aboalfetoh, AY; Adayel, HM; Asla, MM; Brakat, AM; Rizk, MA | 1 |
| Netticadan, T; Raj, P; Thandapilly, SJ; Wigle, J; Zieroth, S | 1 |
| Howlett, LA; Jones, SA; Lancaster, MK | 1 |
| Franczyk, B; Gluba-Brzózka, A; Rysz, J; Rysz-Górzyńska, M | 1 |
| Grużewska, K; Gul-Hinc, S; Jankowska-Kulawy, A; Michno, A; Ronowska, A; Zyśk, M | 1 |
| Briansó-Llort, L; Hernandez, C; Ramos-Perez, L; Selva, DM; Simó, R; Simó-Servat, O; Torres-Torronteras, J | 1 |
| Amiri, H; Homayouni-Tabrizi, M; Hosseini, H; Rajabian, A; Teimouri, M | 1 |
| Li, H; Li, Y; Su, M; Weng, J; Xu, S; Zhao, W | 1 |
| A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
| Becherescu, A; Butnariu, M; Cruz-Martins, N; Ekaterina Robertovna, G; Fratantonio, D; Herrera-Bravo, J; Iriti, M; Kumar, M; Les, F; López, V; Martorell, M; Pentea, M; Rasul Suleria, HA; Sarac, I; Setzer, WN; Sharifi-Rad, J; Sukreet, S | 1 |
| Bryl, A; Falkowski, M; Mrugacz, M; Zorena, K | 1 |
| Castaldo, L; Gaspari, A; Graziani, G; Izzo, L; Minno, GD; Narváez, A; Ritieni, A | 1 |
| Anton, SD; Buford, TW; Leeuwenburgh, C; Manini, TM; Mankowski, RT; Qiu, P; Schneider, S; You, L | 1 |
| Berretta, M; Bignucolo, A; Ceccarelli, M; Comello, F; Di Francia, R; Facchini, G; Iaffaioli, RV; Maurea, N; Quagliariello, V | 1 |
| Banez, MJ; Biswas, OS; Bryan, NS; Chandra, A; Geluz, MI; Hamdan, T; Von Schwarz, ER | 1 |
| Basili, S; Cangemi, R; Corica, B; Raparelli, V; Romiti, GF | 1 |
| Athukorala, M; Evans, LW; Ferguson, BS; Martinez-Guryn, K | 1 |
| Eltutan, IB; Ercan, I; Genc, S; Olcum, M; Tastan, B | 1 |
| Chang, JF; Chen, BH; Chen, PJ; Hou, YC; Liu, WC; Lu, CL; Lu, KC; Shen, TC; Song, JY; Zheng, CM | 1 |
| Campiglia, P; Carrizzo, A; Ciccarelli, M; Di Pietro, P; Forte, M; Frati, G; Galasso, G; Izzo, C; Rubattu, S; Sciarretta, S; Sommella, E; Vecchione, C; Venturini, E | 1 |
| Banach, J; Bujak, R; Chudzińska, M; Grześk, G; Rogowicz, D; Sielski, S; Sinkiewicz, A; Wołowiec, Ł | 1 |
| Dludla, PV; Louw, J; Mazibuko-Mbeje, SE; Mokgalaboni, K; Mxinwa, V; Nkambule, BB; Nyambuya, TM; Orlando, P; Silvestri, S; Tiano, L | 1 |
| Alirezaei, A; Asgharpour, M | 1 |
| Hou, CY; Hsu, CN; Tain, YL | 1 |
| Ćirković Veličković, T; Gligorijević, N; Khulal, U; Nedić, O; Radomirović, M; Stanić-Vučinić, D; Stojadinović, M | 1 |
| Asghari, A; Jamialahmadi, T; Parsamanesh, N; Sahebkar, A; Sardari, S; Tasbandi, A; Xu, S | 1 |
| Cho, S; Han, J; Ihm, J; Kim, HK; Namkoong, K; Park, J; Shin, M; Thu, VT; Yang, E | 1 |
| Bonaventura, A; Carbone, F; Dallegri, F; Liberale, L; Montecucco, F | 1 |
| Abrams, SL; Candido, S; Cervello, M; Cocco, L; Gizak, A; Lertpiriyapong, K; Libra, M; Martelli, AM; McCubrey, JA; Montalto, G; Rakus, D; Ratti, S; Steelman, LS | 1 |
| Chen, J; Gao, K; Jia, C; Murtaza, G; Tian, G; Wahab, A; Zhang, F | 1 |
| Brianso-Llort, L; Hammond, GL; Saez-Lopez, C; Selva, DM; Simó, R; Torres-Torronteras, J | 1 |
| Abrams, SL; Candido, S; Cervello, M; Cocco, L; Gizak, A; Lertpiriyapong, K; Libra, M; Lombardi, P; Martelli, AM; McCubrey, JA; Montalto, G; Murata, RM; Rakus, D; Ratti, S; Rosalen, PL; Steelman, LS | 1 |
| Chedea, VS; Frosini, M; Maioli, E; Pessina, F; Sticozzi, C; Valacchi, G; Vicaş, SI | 1 |
| Bird, JK; Raederstorff, D; Steinert, RE; Weber, P | 1 |
| Li, S; Li, YR; Lin, CC | 1 |
| Chiou, YS; Ho, CT; Lee, PS; Pan, MH | 1 |
| Granchi, C; Minutolo, F | 1 |
| Bernardi, A; de Sá Coutinho, D; Frozza, RL; Pacheco, MT | 1 |
| Álvarez, R; Balada, C; Flores, G; Guzmán, L; Knox, M; Martínez, JL; Vinet, R | 1 |
| Kulashekar, M; Peuler, JD; Stom, SM | 1 |
| Berco, M; Bhavnani, BR; Cecutti, A; Gerulath, A; Woolever, AC | 1 |
| Górski, K; Malinowski, B; Pawlak-Osińska, K; Rewerski, S; Socha, M; Walczak, M; Wiciński, M; Wódkiewicz, E | 1 |
| Lamuela-Raventós, RM; Laveriano-Santos, EP; Marhuenda-Muñoz, M; Ramírez-Garza, SL; Storniolo, CE; Tresserra-Rimbau, A; Vallverdú-Queralt, A | 1 |
| Li, Y; Liu, Q; Liu, Y; Wang, DW; Yan, X; Zhao, YH | 1 |
| Bhatnagar, A; Pannu, N | 1 |
| Chan, L; Louis, XL; Netticadan, T; Raj, P; Wigle, JT; Zieroth, S | 1 |
| Annunziata, G; Ciampaglia, R; Maisto, M; Narciso, V; Novellino, E; Schisano, C; Tenore, GC | 1 |
| Dyck, GJB; Dyck, JRB; Ezekowitz, JA; Raj, P; Zieroth, S | 1 |
| He, J; Li, J; Liu, F; Liu, J; Liu, Y; Qi, Z; Shen, Y; Sumi, S; Tian, W; Yang, L; Zhang, Q | 1 |
| Abdelgawad, IY; Grant, MKO; Zordoky, BN | 1 |
| Atanasov, AG; Breuss, JM; Uhrin, P | 1 |
| Cao, Y; Kong, L; Smith, W; Yan, L | 1 |
| Andreoletti, P; Cherkaoui-Malki, M; Latruffe, N; Silva, P; Sureda, A; Tur, JA | 1 |
| Anhê, FF; Choi, BSY; Dyck, JRB; Marette, A; Schertzer, JD | 1 |
| Yamagata, K | 1 |
| Mochly-Rosen, D; Zakhari, S | 1 |
| Lançon, A; Latruffe, N; Michaille, JJ | 1 |
| Vang, O | 1 |
| Espín, JC; García-Almagro, FJ; García-Conesa, MT; Gonzálvez, M; Larrosa, M; Ruiz-Ros, JA; Tomás-Barberán, FA; Tomé-Carneiro, J; Yáñez-Gascón, MJ | 2 |
| Buckley, JD; Coates, AM; Howe, PR; Wong, RH | 1 |
| Aujard, F; Marchal, J; Pifferi, F | 1 |
| Chu, LM; Elmadhun, NY; Lassaletta, AD; Robich, MP; Sabe, AA; Sellke, FW | 1 |
| Kunz, I; Raederstorff, D; Schwager, J | 1 |
| Bartolo, M; Carrizzo, A; Damato, A; Forte, M; Maciag, A; Puca, AA; Salzano, F; Trimarco, V; Vecchione, C | 1 |
| Micans, P | 1 |
| Crandall, JP; Pollack, RM | 1 |
| Sahebkar, A | 1 |
| Resurreccion, AV; Sales, JM | 1 |
| Koh, KK; Lim, S; Quon, MJ | 1 |
| Andres-Lacueva, C; Bandinelli, S; Bartali, B; Cherubini, A; Ferrucci, L; Semba, RD; Sun, K; Urpí-Sarda, M; Zamora-Ros, R | 1 |
| Chan, SW; Gyda, M; Ho, S; Ng, YF; Tang, PC | 1 |
| Barale, R; Bavaresco, L; Faliva, MA; Gerbi, V; Giacosa, A; La Vecchia, C; Negri, E; Opizzi, A; Perna, S; Pezzotti, M; Rondanelli, M | 1 |
| Parazzini, F | 1 |
| Howes, MJ; Simmonds, MS | 1 |
| Bacaksız, A; Göktekin, Ö; İzmirli, M; Kılıç, Ü; Uysal, Ö | 1 |
| Förstermann, U; Li, H; Xia, N | 2 |
| Anthony, NG; Gray, AI; Lim, KG; Mackay, SP; Pyne, NJ; Pyne, S | 1 |
| Artero, A; Cano, A; Tarín, JJ | 1 |
| Dyck, JR; Robertson, IM; Zordoky, BN | 1 |
| van Wensem, J | 1 |
| Du, AL; Liu, JL; Meng, C | 1 |
| Aires, V; Delmas, D | 1 |
| Mensink, RP; Plat, J; van der Made, SM | 1 |
| Coulson, FR; Fenning, AS; Pullen, C; Vella, RK | 1 |
| Bertelli, AA; Biagi, M | 1 |
| Banach, M; Graham, IM; Lip, GY; Mikhailidis, DP; Muntner, P; Rizzo, M; Rysz, J; Sahebkar, A; Serban, C; Sperling, LS; Ursoniu, S; Wong, ND | 1 |
| Fu, DG | 1 |
| Ahmad, N; Liu, X; Singh, CK | 1 |
| Bath, S; Elbarbry, F; Malhotra, A | 1 |
| Adibi, P; Faghihzadeh, F; Hekmatdoost, A | 1 |
| Andres-Lacueva, C; Rabassa, M; Urpi-Sarda, M; Zamora-Ros, R | 1 |
| Li, P; Lin, N; Liu, A; Zhang, L; Zhou, C | 1 |
| Davidge, ST; Fung, D; Morton, JS; Reyes, LM; Schneider, J; Shah, A | 1 |
| Pagliaro, B; Rubattu, S; Santolamazza, C; Simonelli, F | 1 |
| Belmonte-de-Abreu, PS; Cereser, KM; Francesconi, LP; Franco, VC; Lobato, MI; Zortea, K | 1 |
| Bonnefont-Rousselot, D | 1 |
| Fenning, AS; Irwin, JC; Phyu, HE; Vella, RK | 1 |
| Cheserek, MJ; Karangwa, E; Le, G; Li, L; Shi, Y; Wu, G | 1 |
| Al Sayah, L; Bachschmid, MM; Cohen, RA; Fry, JL; Seta, F; Van Roy, I; Weisbrod, RM; Weng, X | 1 |
| Chen, G; Huang, H; Liao, D; Pu, R; Xue, X; Zhu, Y | 1 |
| Bobryshev, YV; Chistiakov, DA; Orekhov, AN | 1 |
| Davidge, ST; Morton, JS; Quon, A; Shah, A | 1 |
| Lam, KS; Liu, L; Wang, Y; Xu, A | 1 |
| Almeida, LM; Brito, PM; Dinis, TC; Simões, NF | 1 |
| Knutson, MD; Leeuwenburgh, C | 1 |
| Andriantsitohaina, R; Lagrue-Lak-Hal, AH | 1 |
| Collins, MA; Das, DK; Gray, MO; Korthuis, RJ; Mukamal, KJ; Neafsey, EJ; Parks, DA | 1 |
| Abeywardena, MY; Leifert, WR | 1 |
| Bajer, M; Bezbradica, S; Buzek, F; Dingermann, T; Renz, H; Schröder, K; Song, M; Zündorf, I | 1 |
| Das, DK; Goswami, SK | 1 |
| Arora, R; Sadruddin, S | 1 |
| Anton, SD; Bernabei, R; Carter, CS; Leeuwenburgh, C; Marzetti, E; Wohlgemuth, SE | 1 |
| Fullerton, MD; Steinberg, GR | 1 |
| Fan, E; Zhang, K | 1 |
| Favaloro, EJ; Franchini, M; Lippi, G; Targher, G | 1 |
| Bagi, Z; Csiszar, A; de Cabo, R; Feher, A; Pearson, K; Recchia, FA; Sonntag, WE; Ungvari, Z | 1 |
| Haskó, G; Pacher, P | 1 |
| Jones, PJ; Ramprasath, VR | 1 |
| Brown, L; Chan, V; Chunduri, P; Iyer, A; Kroon, PA | 1 |
| de Cabo, R; Mercken, EM | 1 |
| Berry, NM; Buckley, JD; Coates, AM; Howe, PR; Kunz, I; Wong, RH | 1 |
| Abu-Taha, M; Cerda-Nicolas, JM; Cortijo, J; Estañ, L; Hermenegildo, C; Issekutz, AC; Morcillo, EJ; Orallo, F; Piqueras, L; Rius, C; Sanz, MJ | 1 |
| Das, DK; Das, M | 1 |
| Borriello, A; Cucciolla, V; Della Ragione, F; Galletti, P | 1 |
| Brown, L; Chan, V; Fenning, A; Hoey, A; Iyer, A | 1 |
| Chong-Han, K | 1 |
| Kelly, G | 1 |
| Kelly, GS | 1 |
| Das, DK; Gurusamy, N; Petrovski, G | 1 |
| Csiszar, A | 1 |
| Boldogh, I; Calderón-Cortés, E; Clemente-Guerrero, M; Cortés-Rojo, C; Godínez-Hernández, D; Gutiérrez-Pérez, A; Manzo-Avalos, S; Noriega-Cisneros, R; Saavedra-Molina, A | 1 |
| Li, JJ; Qian, HY; Wang, H; Xu, H; Yang, YJ; Zhang, Q | 1 |
| Baur, JA; Hausenblas, HA; Smoliga, JM | 1 |
| Ebersole, J; González, O; Novak, MJ; Tobia, C | 1 |
| Dolinsky, VW; Dyck, JR | 1 |
| Nakashima, Y; Takahashi, S | 1 |
| Fu, YC; Wang, W; Yu, W | 1 |
| Dyck, JR; Sung, MM | 1 |
| Bonnefont-Rousselot, D; Borderie, D; Frombaum, M; Le Clanche, S | 1 |
| Babicz, K; Malinowska, J; Olas, B; Oleszek, W; Stochmal, A | 1 |
| Andres-Lacueva, C; Arós, F; Estruch, R; Fitó, M; Lamuela-Raventós, RM; Lapetra, J; Martínez-González, MÁ; Salas-Salvadó, J; Urpi-Sarda, M; Zamora-Ros, R | 1 |
| Burdan, F; Fraczek, M; Podlodowska, J; Szumiło, J | 1 |
| Avilés-Plaza, F; Espín, JC; García-Almagro, FJ; García-Conesa, MT; Gonzálvez, M; Larrosa, M; Parra, S; Ruiz-Ros, JA; Tomás-Barberán, FA; Tomé-Carneiro, J; Yáñez-Gascón, MJ | 1 |
| Lu, XQ; Ruan, BF; Song, J; Zhu, HL | 1 |
| Ginter, E; Simko, V | 1 |
| Si, LY; Xu, Q | 1 |
| He, S; Yan, X | 1 |
| Bourzac, K | 1 |
| Bo, S; Cassader, M; Castiglione, A; Cavallo-Perin, P; Ciccone, G; De Michieli, F; Durazzo, M; Gambino, R; Villois, P | 1 |
| Binkoski, AE; Bonanome, A; Coval, SM; Etherton, TD; Griel, AE; Hecker, KD; Hilpert, KF; Kris-Etherton, PM | 1 |
| Mahyar-Roemer, M; Roemer, K | 1 |
| Boucher, F; de Leiris, J; de Lorgeril, M; Guiraud, A; Salen, P | 1 |
| Berdeaux, A; Casper, RF; Savouret, JF | 1 |
| Hao, HD; He, LR | 1 |
| Barenghi, L; Bradamante, S; Villa, A | 1 |
| Dong, HH; Ren, HL | 1 |
| Delmas, D; Jannin, B; Latruffe, N | 1 |
| Csiszar, A; Labinskyy, N; Oroszi, G; Pacher, P; Stef, G; Ungvari, Z; Veress, G; Wu, J | 1 |
| Bertelli, AA | 1 |
| Shankar, S; Singh, G; Srivastava, RK | 1 |
| Liu, BL; Zhang, W; Zhang, X; Zhen, HN | 1 |
| Das, DK; Das, S | 1 |
| Brameld, JM; Nicholson, SK; Tucker, GA | 1 |
| Mattivi, F | 1 |
| Celotti, E; Conte, LS; Ferrarini, R; Zironi, R | 1 |
| Chien, PY; Gehm, BD; Jameson, JL; McAndrews, JM | 1 |
| Lin, JK; Tsai, SH | 1 |
| Olas, B; Wachowicz, B | 1 |
125 review(s) available for resveratrol and Cardiovascular Diseases
| Article | Year |
|---|---|
Human disorders associated with inflammation and the evolving role of natural products to overcome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biological Products; Cardiovascular Diseases; Humans; Inflammation; Neoplasms; Skin Diseases | 2019 |
The Effect of Resveratrol on the Cardiovascular System from Molecular Mechanisms to Clinical Results.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cardiovascular Diseases; Cardiovascular System; COVID-19; COVID-19 Drug Treatment; Humans; Resveratrol | 2021 |
The effects of resveratrol on glycemic control and cardiometabolic parameters in patients with T2DM: A systematic review and meta-analysis.
Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Glycemic Control; Humans; Insulin Resistance; Resveratrol | 2022 |
A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure.
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Heart Failure; Humans; Myocardial Infarction; Resveratrol | 2021 |
Pharmacy and Exercise as Complimentary Partners for Successful Cardiovascular Ageing.
Topics: Adrenergic beta-Antagonists; Aged; Aging; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cardiovascular System; Exercise; Humans; Metformin; Peptidyl-Dipeptidase A; Pharmacy; Quality of Life; Receptors, Adrenergic; Resveratrol | 2022 |
Ageing, Age-Related Cardiovascular Risk and the Beneficial Role of Natural Components Intake.
Topics: Aging; Cardiovascular Diseases; Carotenoids; Cellular Senescence; Diet; Flavonoids; Humans; Oxidative Stress; Resveratrol; Risk Factors | 2021 |
Anti-inflammatory effects of resveratrol in patients with cardiovascular disease: A systematic review and meta-analysis of randomized controlled trials.
Topics: Anti-Inflammatory Agents; Biomarkers; Cardiovascular Diseases; Dietary Supplements; Humans; Inflammation; Interleukin-6; Randomized Controlled Trials as Topic; Resveratrol; Tumor Necrosis Factor-alpha | 2022 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Plant-food-derived Bioactives in Managing Hypertension: From Current Findings to Upcoming Effective Pharmacotherapies.
Topics: Anthocyanins; Cardiovascular Diseases; Flavonoids; Humans; Hypertension; Lignans; Plant Extracts; Polyphenols; Resveratrol | 2023 |
A Mediterranean Diet May Be Protective in the Development of Diabetic Retinopathy.
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Retinopathy; Diet, Mediterranean; Fabaceae; Olive Oil; Polyphenols; Resveratrol; Vegetables | 2023 |
Red Wine Consumption and Cardiovascular Health.
Topics: Alcohol Drinking; Alcoholic Beverages; Antioxidants; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Flavones; Glucose; Humans; Oxidative Stress; Polyphenols; Resveratrol; Wine | 2019 |
Resveratrol in Cancer Patients: From Bench to Bedside.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cardiovascular Diseases; Chemical Phenomena; Clinical Studies as Topic; Drug Evaluation, Preclinical; Drug Interactions; Humans; Neoplasms; Resveratrol; Structure-Activity Relationship; Translational Research, Biomedical; Treatment Outcome | 2020 |
A systemic review on the antioxidant and anti-inflammatory effects of resveratrol, curcumin, and dietary nitric oxide supplementation on human cardiovascular health.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Cardiovascular System; Clinical Trials as Topic; Curcumin; Dietary Supplements; Humans; Nitric Oxide; Resveratrol | 2020 |
The Role of Histone Acetylation and the Microbiome in Phytochemical Efficacy for Cardiovascular Diseases.
Topics: Acetylation; Animals; Cardiovascular Diseases; Catechin; Curcumin; Epigenesis, Genetic; Histone Deacetylases; Histones; Humans; Microbiota; Phytochemicals; Protein Processing, Post-Translational; Resveratrol | 2020 |
Inhibitory effects of phytochemicals on NLRP3 inflammasome activation: A review.
Topics: Animals; Cardiovascular Diseases; Central Nervous System Diseases; Curcumin; Humans; Inflammasomes; Inflammation; Isothiocyanates; NLR Family, Pyrin Domain-Containing 3 Protein; Phytochemicals; Resveratrol; Signal Transduction; Sulfoxides | 2020 |
Influence of Resveratrol on the Cardiovascular Health Effects of Chronic Kidney Disease.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Humans; Renal Insufficiency, Chronic; Resveratrol; Risk Factors | 2020 |
A Novel Promising Frontier for Human Health: The Beneficial Effects of Nutraceuticals in Cardiovascular Diseases.
Topics: Berberine; Biological Products; Brassica; Cardiovascular Diseases; Curcumin; Dietary Supplements; Health; Quercetin; Resveratrol; Spirulina | 2020 |
Resveratrol and cardiovascular system-the unfulfilled hopes.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Cardiovascular System; Humans; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes | 2021 |
A Meta-Analysis of the Impact of Resveratrol Supplementation on Markers of Renal Function and Blood Pressure in Type 2 Diabetic Patients on Hypoglycemic Therapy.
Topics: Antioxidants; Biomarkers; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dietary Supplements; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Kidney Diseases; Kidney Function Tests; Resveratrol | 2020 |
Herbal antioxidants in dialysis patients: a review of potential mechanisms and medical implications.
Topics: Antioxidants; Cardiovascular Diseases; Curcumin; Emodin; Humans; Inflammation; Oxidative Stress; Plant Extracts; Quercetin; Renal Dialysis; Renal Insufficiency, Chronic; Resveratrol; Silymarin | 2021 |
Preventive Aspects of Early Resveratrol Supplementation in Cardiovascular and Kidney Disease of Developmental Origins.
Topics: Animals; Cardiovascular Diseases; Humans; Kidney Diseases; Oxidative Stress; Resveratrol; Signal Transduction | 2021 |
Role of Resveratrol in Prevention and Control of Cardiovascular Disorders and Cardiovascular Complications Related to COVID-19 Disease: Mode of Action and Approaches Explored to Increase Its Bioavailability.
Topics: Biological Availability; Cardiovascular Diseases; COVID-19; COVID-19 Drug Treatment; Humans; Resveratrol; SARS-CoV-2 | 2021 |
Resveratrol and endothelial function: A literature review.
Topics: Angiogenesis Inhibitors; Animals; Antihypertensive Agents; Cardiovascular Agents; Cardiovascular Diseases; Endothelial Cells; Endothelium, Vascular; Fibrinolytic Agents; Humans; Hypoglycemic Agents; Resveratrol; Signal Transduction | 2021 |
Cardiovascular Protective Effects and Clinical Applications of Resveratrol.
Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Cardiotonic Agents; Cardiovascular Diseases; Humans; Hypolipidemic Agents; Phenols; Plant Extracts; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes | 2017 |
Impact of Red Wine Consumption on Cardiovascular Health.
Topics: Alcohol Drinking; Animals; Antioxidants; Cardiotonic Agents; Cardiovascular Diseases; Ethanol; Humans; Resveratrol; Wine | 2019 |
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases.
Topics: Berberine; Cardiovascular Diseases; Curcumin; Gene Expression Regulation; Glycogen Synthase Kinase 3; Humans; Inflammation; Mechanistic Target of Rapamycin Complex 1; Neoplasms; Neurodegenerative Diseases; Osteoarthritis; Phosphatidylinositol 3-Kinases; Protective Agents; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Significance of Resveratrol in Clinical Management of Chronic Diseases.
Topics: Aging; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus; Dose-Response Relationship, Drug; Humans; Neoplasms; Obesity; Polyphenols; Resveratrol; Stilbenes | 2017 |
Resveratrol: from diet to topical usage.
Topics: Animals; Cardiovascular Diseases; Cosmetics; Humans; Resveratrol; Skin; Stilbenes | 2017 |
Cardiovascular and Antiobesity Effects of Resveratrol Mediated through the Gut Microbiota.
Topics: Animals; Anti-Obesity Agents; Cardiovascular Diseases; Diet, High-Fat; Energy Metabolism; Gastrointestinal Microbiome; Humans; Intestinal Mucosa; Obesity; Resveratrol; Stilbenes | 2017 |
Effect of resveratrol and pterostilbene on aging and longevity.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Cardiovascular Diseases; Cataract; Cellular Senescence; Humans; Inflammation; Longevity; Neoplasms; Neurodegenerative Diseases; NF-E2-Related Factor 2; Osteoporosis; Oxidative Stress; Resveratrol; Sirtuin 1; Stilbenes; Telomere Homeostasis | 2018 |
Chemoprevention by resveratrol and pterostilbene: Targeting on epigenetic regulation.
Topics: Anti-Inflammatory Agents; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Bone Diseases; Cardiovascular Diseases; Chemoprevention; DNA Methylation; Epigenesis, Genetic; Histones; Humans; MicroRNAs; Neoplasms; Neurodegenerative Diseases; Protein Processing, Post-Translational; Resveratrol; Stilbenes | 2018 |
Activators of Sirtuin-1 and their Involvement in Cardioprotection.
Topics: Benzimidazoles; Cardiotonic Agents; Cardiovascular Diseases; Cyclooctanes; Ginsenosides; Heterocyclic Compounds, 4 or More Rings; Humans; Lignans; Polycyclic Compounds; Resveratrol; Sirtuin 1 | 2018 |
Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Inflammation; Mice; Neoplasms; Obesity; Rats; Respiratory Tract Diseases; Resveratrol; Stilbenes | 2018 |
Resveratrol's Potential in the Adjunctive Management of Cardiovascular Disease, Obesity, Diabetes, Alzheimer Disease, and Cancer.
Topics: Alzheimer Disease; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus; Humans; Obesity; Resveratrol | 2018 |
Beneficial Effects of Resveratrol Administration-Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions.
Topics: Animals; Cardiovascular Diseases; Cerebrovascular Circulation; Cyclic AMP; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Cytokines; Diabetes Mellitus; Disease Models, Animal; Humans; Inflammation; Platelet Aggregation Inhibitors; Polyphenols; Reactive Oxygen Species; Resveratrol; Sirtuin 1 | 2018 |
Health Effects of Resveratrol: Results from Human Intervention Trials.
Topics: Biological Availability; Cardiovascular Diseases; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Humans; Resveratrol | 2018 |
Pharmacological Effects and Mechanisms of Chinese Medicines Modulating NLRP3 Inflammasomes in Ischemic Cardio/Cerebral Vascular Disease.
Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Drugs, Chinese Herbal; Humans; Inflammasomes; Molecular Targeted Therapy; Morphinans; NLR Family, Pyrin Domain-Containing 3 Protein; Resveratrol; Spirostans | 2018 |
Resveratrol: from enhanced biosynthesis and bioavailability to multitargeting chronic diseases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biological Availability; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus; Drug Delivery Systems; Humans; Neoplasms; Obesity; Protein Biosynthesis; Resveratrol | 2019 |
Are the cardioprotective effects of the phytoestrogen resveratrol sex-dependent?
Topics: Animals; Cardiotonic Agents; Cardiovascular Diseases; Humans; Phytoestrogens; Resveratrol; Sex Characteristics | 2019 |
The Effects of Resveratrol in Patients with Cardiovascular Disease and Heart Failure: A Narrative Review.
Topics: Anti-Inflammatory Agents; Biomarkers; Blood Pressure; Cardiovascular Diseases; Endothelial Cells; Heart Failure; Humans; Hypoglycemic Agents; Resveratrol; Treatment Outcome; Ventricular Function, Left | 2019 |
Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology.
Topics: Animals; Antineoplastic Agents; Cardiotonic Agents; Cardiovascular Diseases; Cell Line, Tumor; Humans; Medical Oncology; Mice; Neoplasms; Resveratrol | 2019 |
Resveratrol and Its Effects on the Vascular System.
Topics: Animals; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Clinical Trials as Topic; Disease Models, Animal; Humans; Resveratrol | 2019 |
Overview of Cellular Mechanisms and Signaling Pathways of Piceatannol.
Topics: Animals; Cardiovascular Diseases; Cell Cycle; Fabaceae; Humans; Neoplasms; Neuroprotection; Phytotherapy; Protein Kinase Inhibitors; Resveratrol; Signal Transduction; Stilbenes | 2020 |
How efficient is resveratrol as an antioxidant of the Mediterranean diet, towards alterations during the aging process?
Topics: Animals; Antioxidants; Cardiovascular Diseases; Diet, Mediterranean; Healthy Aging; Humans; Neoplasms; Resveratrol | 2019 |
Host-Microbe Interplay in the Cardiometabolic Benefits of Dietary Polyphenols.
Topics: Animals; Cardiovascular Diseases; Gastrointestinal Microbiome; Humans; Hydrolyzable Tannins; Polyphenols; Proanthocyanidins; Resveratrol | 2019 |
Polyphenols Regulate Endothelial Functions and Reduce the Risk of Cardiovascular Disease.
Topics: Antioxidants; Cardiovascular Diseases; Catechin; Diet; Endothelium, Vascular; Flavonoids; Humans; Polyphenols; Quercetin; Resveratrol | 2019 |
Focus on: The cardiovascular system: what did we learn from the French (Paradox)?
Topics: Alcohol Drinking; Alcoholic Beverages; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Animals; Antioxidants; Binge Drinking; Cardiovascular Diseases; Cardiovascular System; Humans; Resveratrol; Stilbenes; Wine | 2010 |
Effects of dietary phytophenols on the expression of microRNAs involved in mammalian cell homeostasis.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Cell Differentiation; Cell Physiological Phenomena; Diet; Dietary Fiber; Fruit; Gene Expression; Homeostasis; Humans; Inflammation; MicroRNAs; Neoplasms; Phenols; Plants; Polyphenols; Resveratrol; Signal Transduction; Stilbenes; Vegetables | 2013 |
What is new for resveratrol? Is a new set of recommendations necessary?
Topics: Animals; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Neoplasms; Practice Guidelines as Topic; Resveratrol; Stilbenes | 2013 |
Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective.
Topics: Animals; Cardiotonic Agents; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Primary Prevention; Resveratrol; Secondary Prevention; Stilbenes; Vitis; Wine | 2013 |
Evidence for circulatory benefits of resveratrol in humans.
Topics: Animals; Cardiovascular Diseases; Humans; Resveratrol; Stilbenes; Vasodilator Agents | 2013 |
Resveratrol in mammals: effects on aging biomarkers, age-related diseases, and life span.
Topics: Aging; Animals; Antioxidants; Biomarkers; Cardiovascular Diseases; Humans; Longevity; Mammals; Resveratrol; Stilbenes | 2013 |
The pig as a valuable model for testing the effect of resveratrol to prevent cardiovascular disease.
Topics: Animals; Cardiotonic Agents; Cardiovascular Diseases; Disease Models, Animal; Humans; Resveratrol; Species Specificity; Stilbenes; Swine; Treatment Outcome | 2013 |
Resveratrol, from experimental data to nutritional evidence: the emergence of a new food ingredient.
Topics: Animals; Biomedical Research; Caloric Restriction; Cardiovascular Diseases; Dietary Supplements; Food; Humans; Nutritional Status; Resveratrol; Statistics as Topic; Stilbenes | 2013 |
Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases.
Topics: Antioxidants; Biological Availability; Cardiovascular Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Diabetes Mellitus; Humans; Metabolic Diseases; Oxidation-Reduction; Oxidative Stress; Resveratrol; Stilbenes | 2013 |
Resveratrol: therapeutic potential for improving cardiometabolic health.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Glucose Metabolism Disorders; Humans; Inflammation; Oxidative Stress; Resveratrol; Stilbenes | 2013 |
Effects of resveratrol supplementation on plasma lipids: a systematic review and meta-analysis of randomized controlled trials.
Topics: Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Humans; Lipid Metabolism; Lipids; Randomized Controlled Trials as Topic; Resveratrol; Risk Factors; Stilbenes; Triglycerides | 2013 |
Resveratrol in peanuts.
Topics: Alzheimer Disease; Antioxidants; Arachis; Biological Availability; Cardiovascular Diseases; Diet; Humans; Neoplasms; Resveratrol; Stilbenes | 2014 |
Modulation of adiponectin as a potential therapeutic strategy.
Topics: Adiponectin; Antihypertensive Agents; Atherosclerosis; Bariatric Surgery; Cardiovascular Diseases; Clinical Trials as Topic; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Reducing; Exercise; Humans; Hypoglycemic Agents; Insulin Resistance; Life Style; Metabolic Syndrome; Metabolism, Inborn Errors; Obesity; Peroxisome Proliferator-Activated Receptors; Receptors, Adiponectin; Resveratrol; Stilbenes | 2014 |
Resveratrol and cardiovascular health--promising therapeutic or hopeless illusion?
Topics: Animals; Cardiotonic Agents; Cardiovascular Diseases; Humans; Resveratrol; Stilbenes | 2014 |
Mediterranean Way of Drinking and Longevity.
Topics: Alcohol Drinking; Cardiovascular Diseases; Diet, Mediterranean; Female; Flavonols; Humans; Liver Cirrhosis; Longevity; Male; Mediterranean Region; Neoplasms; Phenols; Resveratrol; Risk Factors; Sex Factors; Sirtuins; Stilbenes; Wine | 2016 |
Resveratrol, inositol, vitamin D and K in the prevention of cardiovascular and osteoporotic risk: a novel approach in peri- and postmenopause.
Topics: Animals; Cardiovascular Diseases; Cell Line; Female; Humans; Inositol; Mice; Osteoporosis, Postmenopausal; Perimenopause; Postmenopause; Resveratrol; Risk Factors; Stilbenes; Vitamin D; Vitamin K | 2014 |
The role of phytochemicals as micronutrients in health and disease.
Topics: Cardiovascular Diseases; Catechin; Clinical Trials as Topic; Curcuma; Curcumin; Dementia; Diabetes Mellitus; Humans; Micronutrients; Neoplasms; Phytochemicals; Plant Extracts; Resveratrol; Stilbenes; Tea; Vitis; Wine | 2014 |
Resveratrol and endothelial nitric oxide.
Topics: Animals; Cardiovascular Diseases; Endothelial Cells; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Protein Binding; Resveratrol; Stilbenes | 2014 |
Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Binding Sites; Cardiovascular Diseases; Drug Discovery; Humans; Molecular Docking Simulation; Molecular Structure; Neoplasms; Neurodegenerative Diseases; Resveratrol; Signal Transduction; Sphingolipids; Stilbenes | 2014 |
The impact of moderate wine consumption on health.
Topics: Antioxidants; Cardiovascular Diseases; Humans; Resveratrol; Stilbenes; Vitis; Wine | 2015 |
Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases.
Topics: Animals; Blood Pressure; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Heart Rate; Humans; Resveratrol; Stilbenes; Vasodilation | 2015 |
Common pathways in health benefit properties of RSV in cardiovascular diseases, cancers and degenerative pathologies.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Humans; Neoplasms; Neurodegenerative Diseases; Polyphenols; Resveratrol; Signal Transduction; Stilbenes; Wine | 2015 |
Wine, alcohol and pills: What future for the French paradox?
Topics: Alcohol Drinking; Animals; Biological Availability; Cardiovascular Diseases; France; Humans; Polyphenols; Resveratrol; Stilbenes; Wine | 2015 |
Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors--Results from a systematic review and meta-analysis of randomized controlled trials.
Topics: Antioxidants; C-Reactive Protein; Cardiotonic Agents; Cardiovascular Diseases; Female; Humans; Male; Prognosis; Randomized Controlled Trials as Topic; Resveratrol; Risk Assessment; Severity of Illness Index; Stilbenes; Survival Rate; Treatment Outcome | 2015 |
Regulation of redox signalling and autophagy during cardiovascular diseases-role of resveratrol.
Topics: Animals; Antioxidants; Autophagy; Cardiovascular Diseases; Humans; Oxidation-Reduction; Resveratrol; Stilbenes | 2015 |
Resveratrol, in its natural combination in whole grape, for health promotion and disease management.
Topics: Animals; Cardiovascular Diseases; Clinical Trials as Topic; Diet; Disease Management; Fruit; Humans; Metabolic Diseases; Resveratrol; Stilbenes; Vitis | 2015 |
An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cardiovascular Diseases; Central Nervous System; Humans; Kidney Diseases; Metabolic Diseases; Neuroprotective Agents; Resveratrol; Sirtuin 1; Stilbenes | 2015 |
Resveratrol metabolite profiling in clinical nutrition research--from diet to uncovering disease risk biomarkers: epidemiological evidence.
Topics: Animals; Biomarkers; Cardiotonic Agents; Cardiovascular Diseases; Diet; Humans; Nutrition Assessment; Resveratrol; Stilbenes | 2015 |
Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art.
Topics: Animals; Cardiovascular Diseases; Humans; Mice; Phytochemicals; Plant Extracts; Protective Agents; Resveratrol; Stilbenes | 2015 |
Resveratrol and Cardiovascular Diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Dietary Fats; Humans; Resveratrol; Stilbenes; Wine | 2016 |
The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials.
Topics: Biomarkers; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Humans; Insulin Resistance; Meta-Analysis as Topic; Obesity; Overweight; Randomized Controlled Trials as Topic; Reproducibility of Results; Resveratrol; Risk Factors; Stilbenes | 2016 |
Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
Topics: Animals; Antioxidants; Cardiovascular Diseases; DNA Methylation; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histones; Humans; Resveratrol; Stilbenes | 2017 |
Moderate wine consumption in the prevention of metabolic syndrome and its related medical complications.
Topics: Alcohol Drinking; Animals; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Metabolic Syndrome; Randomized Controlled Trials as Topic; Resveratrol; Stilbenes; Wine | 2008 |
Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases.
Topics: Aging; Animals; Biological Availability; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Enzyme Activation; Enzyme Activators; Humans; Inflammation; Neurodegenerative Diseases; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes | 2008 |
Red wine and cardiovascular risks.
Topics: Alcohol Drinking; Animals; Aorta; Atherosclerosis; Cardiovascular Diseases; Color; Endothelium, Vascular; Flavonoids; Humans; Models, Animal; Phenols; Polyphenols; Resveratrol; Risk Assessment; Stilbenes; Thrombosis; Vascular Diseases; Vasodilator Agents; Wine | 2006 |
Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies.
Topics: Alcohol Drinking; Animals; Antioxidants; Cardiotonic Agents; Cardiovascular Diseases; Central Nervous System Depressants; Dementia; Ethanol; Humans; Neuroprotective Agents; Nitric Oxide; Protein Kinase C; Resveratrol; Stilbenes | 2009 |
Cardioprotective actions of grape polyphenols.
Topics: Antioxidants; Cardiovascular Diseases; Flavonoids; Fruit; Humans; Inflammation; Oxidative Stress; Phenols; Phytotherapy; Plant Preparations; Platelet Aggregation; Polyphenols; Resveratrol; Seeds; Stilbenes; Vasodilation; Vitis; Wine | 2008 |
Resveratrol and chemoprevention.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Cardiovascular Diseases; Drug Evaluation, Preclinical; Gene Expression Regulation; Humans; Neoplasms; Neoplasms, Hormone-Dependent; Phytoestrogens; Resveratrol; Signal Transduction; Stilbenes | 2009 |
Resveratrol: biologic and therapeutic implications.
Topics: Animals; Blood Glucose; Caloric Restriction; Cardiovascular Agents; Cardiovascular Diseases; Dietary Carbohydrates; Dietary Fats; Energy Intake; Homeostasis; Humans; Lipid Metabolism; Metabolic Syndrome; Molecular Structure; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes | 2009 |
Cellular mechanisms of cardioprotection by calorie restriction: state of the science and future perspectives.
Topics: Aged; Animals; Antioxidants; Apoptosis; Autophagy; Caloric Restriction; Cardiovascular Diseases; Disease Models, Animal; Forecasting; Heart Diseases; Homeostasis; Humans; Inflammation; Inflammation Mediators; Mitochondria, Heart; Mitochondrial Diseases; Obesity; Oxidation-Reduction; Oxidative Stress; Resveratrol; Stilbenes | 2009 |
Targeting resveratrol to mitochondria for cardiovascular diseases.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Cardiovascular System; Drug Delivery Systems; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Patents as Topic; Resveratrol; Stilbenes | 2010 |
Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox".
Topics: Alcohol Drinking; Antioxidants; Atherosclerosis; Blood Pressure; Cardiovascular Diseases; Cholesterol, HDL; Coronary Artery Disease; Endothelium, Vascular; Fibrinolysis; Hemostasis; Humans; Resveratrol; Stilbenes; Wine | 2010 |
Anti-atherogenic effects of resveratrol.
Topics: Animals; Antioxidants; Atherosclerosis; Cardiovascular Diseases; Humans; Lipids; Phytotherapy; Plant Extracts; Resveratrol; Stilbenes; Vitis | 2010 |
The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential
Topics: Animals; Antioxidants; Cardiovascular Diseases; Cardiovascular System; Humans; Resveratrol; Stilbenes | 2010 |
Resveratrol. Monograph.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Evidence-Based Medicine; Humans; Inflammation; Metabolic Syndrome; Neoplasms; Phytotherapy; Protective Agents; Resveratrol; Stilbenes | 2010 |
Resveratrol and cardiovascular health.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Health Behavior; Humans; Lipoproteins, LDL; Resveratrol; Stilbenes | 2010 |
Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis.
Topics: Animals; Anti-Inflammatory Agents; Cardiovascular Diseases; Cholesterol; Glucose; Homeostasis; Humans; Macrophages; Myocardial Reperfusion Injury; Platelet Aggregation; Resveratrol; Stilbenes | 2010 |
Dietary lipophilic antioxidants: implications and significance in the aging process.
Topics: Antioxidants; Cardiovascular Diseases; Diet; Dietary Supplements; Free Radicals; Humans; Life Style; Longevity; Oxidative Stress; Resveratrol; Stilbenes; Ubiquinone; Vitamin A; Vitamin E | 2010 |
A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 1.
Topics: Aging; Biological Availability; Cardiovascular Diseases; Enzyme Activators; Humans; Learning; Longevity; Memory; Neoplasms; Nervous System Diseases; Obesity; Phenols; Resveratrol; Sirtuins; Stilbenes | 2010 |
A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2.
Topics: Aging; Biological Availability; Cardiovascular Diseases; Enzyme Activators; Humans; Longevity; Neoplasms; Nervous System Diseases; Obesity; Phenols; Resveratrol; Sirtuins; Stilbenes | 2010 |
Resveratrol in cardiovascular health and disease.
Topics: Animals; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Cell Survival; Health Status; Humans; Longevity; Resveratrol; Stilbenes | 2011 |
Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease.
Topics: Aging; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Humans; Oxidative Stress; Resveratrol; Stilbenes | 2011 |
Resveratrol in cardiovascular disease: what is known from current research?
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Antioxidants; Cardiovascular Diseases; Heart Failure; Humans; Resveratrol; Sirtuin 1; Stilbenes | 2012 |
Resveratrol and health--a comprehensive review of human clinical trials.
Topics: Animals; Biological Availability; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Dietary Supplements; Humans; Liver; Obesity; Oxidative Stress; Resveratrol; Stilbenes; Wine | 2011 |
Caloric restriction and chronic inflammatory diseases.
Topics: Adaptive Immunity; Animals; Biomimetics; Caloric Restriction; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus; Humans; Immunity, Innate; Inflammation; Inflammation Mediators; Insulin-Like Growth Factor I; Metformin; Periodontitis; Resveratrol; Signal Transduction; Sirolimus; Sirtuins; Stilbenes; TOR Serine-Threonine Kinases | 2012 |
Calorie restriction and resveratrol in cardiovascular health and disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Caloric Restriction; Cardiovascular Diseases; Humans; Resveratrol; Stilbenes; Vasodilator Agents | 2011 |
Cellular and molecular effects of resveratrol in health and disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Neurodegenerative Diseases; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes | 2012 |
Age-related cardiovascular disease and the beneficial effects of calorie restriction.
Topics: Aged; Aging; Antimutagenic Agents; Caloric Restriction; Cardiovascular Diseases; Humans; Longevity; Resveratrol; Risk Factors; Stilbenes | 2012 |
Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and *NO bioavailability: Potential benefits to cardiovascular diseases.
Topics: Animals; Antioxidants; Arginine; Biological Availability; Cardiovascular Diseases; Diet, Atherogenic; Endothelium, Vascular; Fatty Acids; Humans; Mice; Nitric Oxide; Oxidative Stress; Polyphenols; Rabbits; Rats; Reactive Oxygen Species; Resveratrol; Stilbenes; Wine | 2012 |
Cardiovascular effects and molecular targets of resveratrol.
Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Humans; Molecular Targeted Therapy; Nitric Oxide; Resveratrol; Stilbenes | 2012 |
[Resveratrol--phytophenol with wide activity].
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents; Atherosclerosis; Cardiovascular Diseases; Chemoprevention; Glucose; Humans; Longevity; Neoplasms; Neurodegenerative Diseases; Resveratrol; Stilbenes | 2012 |
Derivatives of resveratrol: potential agents in prevention and treatment of cardiovascular disease.
Topics: AMP-Activated Protein Kinases; Apoptosis; Cardiovascular Agents; Cardiovascular Diseases; Humans; Hydroxamic Acids; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Resveratrol; Sirtuin 1; Stilbenes | 2012 |
Resveratrol role in cardiovascular and metabolic health and potential mechanisms of action.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Autophagy; Cardiovascular Diseases; Disease Models, Animal; Humans; Metabolic Diseases; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes | 2012 |
From resveratrol to its derivatives: new sources of natural antioxidant.
Topics: Antioxidants; Brain Diseases; Cardiovascular Diseases; Humans; Resveratrol; Stilbenes | 2013 |
Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer.
Topics: Antioxidants; Cardiovascular Diseases; Carotenoids; Chronic Disease; Dietary Fiber; Estrogens, Non-Steroidal; Food; Humans; Isoflavones; Isothiocyanates; Lycopene; Monoterpenes; Neoplasms; Olive Oil; Phenols; Phytoestrogens; Phytosterols; Plant Oils; Plant Preparations; Resveratrol; Stilbenes; Tea | 2002 |
The basis for the chemopreventive action of resveratrol.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cardiovascular Diseases; Humans; Neoplasms; Resveratrol; Stilbenes | 2002 |
The aryl hydrocarbon receptor and its xenobiotic ligands: a fundamental trigger for cardiovascular diseases.
Topics: Cardiovascular Diseases; Humans; Ligands; Nicotiana; Receptors, Aryl Hydrocarbon; Resveratrol; Smoking; Stilbenes; Xenobiotics | 2003 |
Mechanisms of cardiovascular protection by resveratrol.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Antioxidants; Cardiovascular Agents; Cardiovascular Diseases; Cell Division; Humans; Phytoestrogens; Resveratrol; Signal Transduction; Stilbenes | 2004 |
Cardiovascular protective effects of resveratrol.
Topics: Animals; Antioxidants; Cardiotonic Agents; Cardiovascular Diseases; Cholesterol; Dose-Response Relationship, Drug; Humans; Lipid Peroxidation; Myocardial Reperfusion Injury; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes; Time Factors | 2004 |
New progression in the study of protective properties of resveratrol in anticardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Humans; Protective Agents; Resveratrol; Stilbenes | 2004 |
Resveratrol: preventing properties against vascular alterations and ageing.
Topics: Aging; Arteriosclerosis; Cardiovascular Diseases; Foam Cells; Health Promotion; Humans; Lipoproteins; Macrophages; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Oxidative Stress; Platelet Aggregation; Resveratrol; Stilbenes; Vasodilation | 2005 |
Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen.
Topics: Aging; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Humans; Resveratrol; Stilbenes; Vasodilator Agents | 2006 |
Wine, research and cardiovascular disease: instructions for use.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Dose-Response Relationship, Drug; Humans; Plant Extracts; Rats; Research Design; Resveratrol; Stilbenes; Wine | 2007 |
Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential.
Topics: Cardiovascular Diseases; Cell Cycle; Chemoprevention; Chemotherapy, Adjuvant; Diabetes Mellitus; Gene Expression Regulation; Humans; Inflammation; Neoplasms; Neovascularization, Pathologic; Resveratrol; Signal Transduction; Stilbenes | 2007 |
New enlightenment of French Paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Cardiovascular Diseases; Cell Line, Tumor; Cell Transformation, Neoplastic; Clinical Trials as Topic; Diet; Europe; France; Gene Expression Regulation, Neoplastic; Humans; Incidence; Mice; Mice, Inbred A; Neoplasms; Resveratrol; Stilbenes; Wine | 2007 |
Resveratrol: a therapeutic promise for cardiovascular diseases.
Topics: Antioxidants; Cardiovascular Diseases; Flavonoids; Models, Biological; Molecular Structure; Phenols; Polyphenols; Reactive Oxygen Species; Resveratrol; Stilbenes; Wine | 2007 |
Effects of dietary polyphenols on gene expression in human vascular endothelial cells.
Topics: Cardiovascular Diseases; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelin-1; Endothelium, Vascular; Flavonoids; Gene Expression Profiling; Gene Expression Regulation; Humans; Nitric Oxide Synthase; Oligonucleotide Array Sequence Analysis; Phenols; Polyphenols; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; Umbilical Veins | 2008 |
Chemoprevention of cancer and cardiovascular disease by resveratrol.
Topics: Anticarcinogenic Agents; Carcinogens; Cardiovascular Diseases; Cell Cycle; Cyclin D1; Enzyme Inhibitors; Gene Expression Regulation; Growth Substances; Humans; Lipid Peroxidation; Neoplasms; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Reactive Oxygen Species; Receptor Protein-Tyrosine Kinases; Resveratrol; Risk Factors; Rosales; Signal Transduction; Stilbenes; Transcription, Genetic; Wine | 1999 |
[Biological activity of resveratrol].
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Cardiovascular Diseases; Humans; Inflammation; Neoplasms; Resveratrol; Ribonucleotide Reductases; Stilbenes | 2001 |
13 trial(s) available for resveratrol and Cardiovascular Diseases
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Higher dose of resveratrol elevated cardiovascular disease risk biomarker levels in overweight older adults - A pilot study.
Topics: Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Female; Humans; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Male; Overweight; Pilot Projects; Resveratrol; Risk Factors; Vascular Cell Adhesion Molecule-1 | 2020 |
Effects of Grape Pomace Polyphenolic Extract (Taurisolo
Topics: Adult; Bacteria; Cardiovascular Diseases; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Female; Humans; Male; Methylamines; Microbiota; Plant Extracts; Polyphenols; Resveratrol; Vitis | 2019 |
Aortic wave velocity: a noninvasive method to measure the stiffness of arteries and the clinical results of supplements that appear to improve arterial stiffness.
Topics: Adult; Aged; Aging; Arginine; Cardiovascular Diseases; Carnosine; Dietary Supplements; Female; Glycation End Products, Advanced; Guanidines; Humans; Male; Middle Aged; Pulse Wave Analysis; Resveratrol; Risk Factors; Stilbenes; Vascular Stiffness | 2013 |
Resveratrol levels and all-cause mortality in older community-dwelling adults.
Topics: Aged; Cardiovascular Diseases; Cohort Studies; Female; Humans; Incidence; Inflammation; Italy; Male; Mortality; Neoplasms; Prevalence; Prospective Studies; Resveratrol; Stilbenes | 2014 |
Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial.
Topics: Aged; Apolipoprotein A-I; Biomarkers; Cardiovascular Diseases; Cross-Over Studies; Female; Humans; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Obesity; Overweight; Resveratrol; Stilbenes | 2015 |
The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
Topics: Adult; Alanine Transaminase; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Blood Pressure; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Fatty Liver; Female; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plant Extracts; Resveratrol; Risk Factors; Stilbenes; Triglycerides | 2015 |
Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors.
Topics: Adult; Aged; Antioxidants; Blood Glucose; Cardiovascular Diseases; Cholesterol; Dietary Supplements; Double-Blind Method; Humans; Male; Middle Aged; Plant Extracts; Resveratrol; Risk Factors; Schizophrenia; Stilbenes; Triglycerides; Young Adult | 2016 |
Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure.
Topics: Brachial Artery; Cardiovascular Diseases; Cross-Over Studies; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Overweight; Placebos; Resveratrol; Risk Factors; Stilbenes; Vasodilation | 2011 |
High urinary levels of resveratrol metabolites are associated with a reduction in the prevalence of cardiovascular risk factors in high-risk patients.
Topics: Aged; Biomarkers; Biotransformation; Blood Glucose; Cardiovascular Diseases; Chromatography, Liquid; Cross-Sectional Studies; Diet, Mediterranean; Female; Heart Rate; Humans; Linear Models; Lipoproteins, HDL; Male; Middle Aged; Multivariate Analysis; Prevalence; Resveratrol; Solid Phase Extraction; Spain; Stilbenes; Tandem Mass Spectrometry; Triglycerides; Wine | 2012 |
One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Female; Fibrinolysis; Fruit; Humans; Inflammation; Male; Middle Aged; Phytotherapy; Plant Extracts; Resveratrol; Stilbenes; Time Factors; Vitis | 2012 |
Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial.
Topics: Aged; Apolipoproteins B; Cardiovascular Diseases; Dietary Supplements; Female; Follow-Up Studies; Humans; Kidney; Lipids; Lipoproteins, LDL; Liver; Male; Middle Aged; Plant Extracts; Resveratrol; Stilbenes; Thyroid Function Tests; Vitis | 2012 |
Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial.
Topics: Adult; Anti-Inflammatory Agents; Antioxidants; C-Reactive Protein; Cardiovascular Diseases; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Female; Humans; Inflammation; Male; Middle Aged; Oxidative Stress; Placebo Effect; Resveratrol; Risk Factors; Smoking; Stilbenes; Triglycerides | 2013 |
39 other study(ies) available for resveratrol and Cardiovascular Diseases
| Article | Year |
|---|---|
Resveratrol Inhibits Metabolism and Affects Blood Platelet Function in Type 2 Diabetes.
Topics: Blood Platelets; Cardiovascular Diseases; Collagen; Diabetes Mellitus, Type 2; Humans; Platelet Aggregation; Resveratrol; Thrombosis; Thromboxane A2 | 2022 |
Effect of Resveratrol Content in Red Wine on Circulating Sex Hormone-Binding Globulin: Lessons from a Pilot Clinical Trial.
Topics: Cardiovascular Diseases; Cholesterol; Female; Humans; Male; Pilot Projects; Resveratrol; Sex Hormone-Binding Globulin; Wine | 2022 |
Genome-Wide Transcriptional Profiling Reveals PHACTR1 as a Novel Molecular Target of Resveratrol in Endothelial Homeostasis.
Topics: Atherosclerosis; Cardiovascular Diseases; Homeostasis; Human Umbilical Vein Endothelial Cells; Humans; Resveratrol | 2022 |
The Interplay Between Antioxidants and the Immune System: A Promising Field, Still Looking for Answers.
Topics: Antioxidants; Autoimmune Diseases; Cardiovascular Diseases; Humans; Immune System; Metabolic Diseases; Neoplasms; Resveratrol | 2020 |
Resveratrol Increases Hepatic SHBG Expression through Human Constitutive Androstane Receptor: a new Contribution to the French Paradox.
Topics: Alcohol Drinking; Animals; Biopsy; Cardiovascular Diseases; Constitutive Androstane Receptor; Culture Media; Diabetes Mellitus, Type 2; Female; Genes, Reporter; Hep G2 Cells; Humans; Liver; Luciferases; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Transgenic; Receptors, Cytoplasmic and Nuclear; Resveratrol; Sex Hormone-Binding Globulin; Wine | 2017 |
Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals.
Topics: Animals; Antineoplastic Agents; Berberine; Cardiovascular Diseases; Curcumin; Dietary Supplements; Humans; Neoplasms; Resveratrol; Signal Transduction | 2018 |
t-Resveratrol Protects against Acute High Glucose Damage in Endothelial Cells.
Topics: Acetylcholine; Animals; Aorta; Blood Glucose; Cardiovascular Diseases; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Hyperglycemia; Male; Nitric Oxide; Nitroprusside; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Stilbenes; Vasodilation | 2018 |
Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
Topics: Analysis of Variance; Antioxidants; Cardiovascular Diseases; Chromans; Estrogens; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Lipoproteins, LDL; Medroxyprogesterone Acetate; Middle Aged; Oxidation-Reduction; Postmenopause; Probucol; Progestins; Quercetin; Resveratrol; Thiobarbituric Acid Reactive Substances; Treatment Outcome; Vitamin E; Wine | 2018 |
Resveratrol attenuates doxorubicin-induced cardiotoxicity in rats by up-regulation of vascular endothelial growth factor B.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cardiotonic Agents; Cardiotoxicity; Cardiovascular Diseases; Doxorubicin; Male; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Resveratrol; Up-Regulation; Vascular Endothelial Growth Factor B | 2020 |
Can drinking wine really promote longevity? Recent evidence shows the antioxidant resveratrol in wine does not offer a health boost.
Topics: Antioxidants; Cardiovascular Diseases; Dietary Supplements; Humans; Longevity; Resveratrol; Stilbenes; Wine | 2014 |
The effect of the SIRT1 2827 A>G polymorphism, resveratrol, exercise, age and occupation in Turkish population with cardiovascular disease.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cardiovascular Diseases; Case-Control Studies; DNA; Exercise; Female; Gene-Environment Interaction; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Occupations; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Resveratrol; Sirtuin 1; Stilbenes; Turkey | 2015 |
Overview of scientific evidence for chocolate health benefits.
Topics: Antioxidants; Cacao; Cardiovascular Diseases; Cognition; Flavonoids; Functional Food; Humans; Resveratrol; Stilbenes | 2015 |
Cardioprotective effect of resveratrol on atherogenic diet-fed rats.
Topics: Adenylate Kinase; Animals; Antioxidants; Aorta; Cardiovascular Diseases; Catalase; Diet, Atherogenic; Glutathione Peroxidase; Heart; Lipid Metabolism; Lipid Peroxidation; Lipids; Male; Myocardium; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Sirtuin 1; Stilbenes; Superoxide Dismutase | 2014 |
Resveratrol prevents cardiovascular complications in the SHR/STZ rat by reductions in oxidative stress and inflammation.
Topics: Acetylcholine; Animals; Blood Vessels; Body Weight; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Drinking; In Vitro Techniques; Inflammation; Lipid Peroxidation; Male; Microelectrodes; Myocardial Contraction; Nitric Oxide; Nitroprusside; Norepinephrine; Oxidative Stress; Rats, Inbred SHR; Resveratrol; Stilbenes; Streptozocin; Ventricular Function | 2015 |
Sirt 1 activator inhibits the AGE-induced apoptosis and p53 acetylation in human vascular endothelial cells.
Topics: Acetylation; Apoptosis; Benzamides; Cardiovascular Diseases; Caspases; Cells, Cultured; Cytochromes c; Diabetes Mellitus; Endothelial Cells; Glycation End Products, Advanced; Humans; Insulin; Insulin Secretion; Naphthols; Oxidative Stress; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Tumor Suppressor Protein p53 | 2015 |
Effect of resveratrol on metabolic and cardiovascular function in male and female adult offspring exposed to prenatal hypoxia and a high-fat diet.
Topics: Animals; Cardiotonic Agents; Cardiovascular Diseases; Diet, High-Fat; Female; Fetal Hypoxia; Heart; Male; Myocardial Contraction; Myocardium; Pregnancy; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Superoxides; Ventricular Function | 2016 |
Resveratrol shows neuronal and vascular-protective effects in older, obese, streptozotocin-induced diabetic rats.
Topics: Analgesics; Animals; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Endothelium, Vascular; Hyperalgesia; Male; Muscle Contraction; Nervous System; Obesity; Plant Extracts; Polyphenols; Random Allocation; Rats, Wistar; Resveratrol; Stilbenes | 2016 |
Cardioprotective effects of lipoic acid, quercetin and resveratrol on oxidative stress related to thyroid hormone alterations in long-term obesity.
Topics: Animals; Anti-Obesity Agents; Antihypertensive Agents; Antioxidants; Biomarkers; Cardiotonic Agents; Cardiovascular Diseases; Diet, High-Fat; Female; Gene Expression Regulation; Heart Ventricles; Hypertension; Hypothyroidism; Mice, Inbred C57BL; Obesity; Oxidative Stress; Quercetin; Random Allocation; Resveratrol; Stilbenes; Thioctic Acid; Thyroid Hormones; Weight Gain | 2016 |
Vascular Smooth Muscle Sirtuin-1 Protects Against Diet-Induced Aortic Stiffness.
Topics: Animals; Blotting, Western; Cardiovascular Diseases; Diet, High-Fat; Disease Models, Animal; Glucose Tolerance Test; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Muscle, Smooth, Vascular; Obesity; Pulse Wave Analysis; Random Allocation; Real-Time Polymerase Chain Reaction; Resveratrol; Sirtuin 1; Stilbenes; Vascular Cell Adhesion Molecule-1; Vascular Stiffness | 2016 |
Postnatal resveratrol supplementation improves cardiovascular function in male and female intrauterine growth restricted offspring.
Topics: AMP-Activated Protein Kinases; Animals; Body Weight; Cardiovascular Diseases; Eating; Female; Fetal Growth Retardation; Heart; Male; Myocardium; Oxidative Stress; Phosphorylation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2017 |
Resveratrol disrupts peroxynitrite-triggered mitochondrial apoptotic pathway: a role for Bcl-2.
Topics: Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Cardiovascular Diseases; Caspases; Cattle; Cells, Cultured; Cytoprotection; Endothelial Cells; Mitochondria; Oxidative Stress; Peroxynitrous Acid; Proto-Oncogene Proteins c-bcl-2; Receptors, Death Domain; Resveratrol; Signal Transduction; Stilbenes | 2008 |
[Red red wine].
Topics: Antioxidants; Cardiovascular Diseases; Humans; Neurodegenerative Diseases; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes; Wine | 2009 |
Is white wine as "heart healthy" as red wine?
Topics: Antioxidants; Cardiovascular Diseases; Flavonoids; Humans; Phenols; Polyphenols; Resveratrol; Stilbenes; Wine | 2009 |
SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol.
Topics: AMP-Activated Protein Kinases; Animals; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Insulin Resistance; Obesity; Resveratrol; Sirtuin 1; Stilbenes | 2010 |
Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2.
Topics: Animals; Antioxidants; Apoptosis; Cardiovascular Diseases; Cells, Cultured; Coronary Vessels; Cytoprotection; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Femoral Artery; Genes, Reporter; Glucose; Glutathione Synthase; Heme Oxygenase-1; Humans; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Male; Mice; Mice, Inbred ICR; Mice, Knockout; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Response Elements; Resveratrol; RNA Interference; Stilbenes; Transcriptional Activation; Transfection; Vasodilation | 2010 |
Endothelial Nrf2 activation: a new target for resveratrol?
Topics: Animals; Antioxidants; Apoptosis; Cardiovascular Diseases; Cytoprotection; Endothelial Cells; Humans; Mice; NF-E2-Related Factor 2; Oxidative Stress; Response Elements; Resveratrol; Stilbenes; Transcriptional Activation; Vasodilation | 2010 |
A toast to your health, one drink at a time.
Topics: Adipocytes; Alcohol Drinking; Antioxidants; Cardiovascular Diseases; Humans; Metabolic Diseases; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes; Wine | 2010 |
Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation.
Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Cardiovascular Diseases; Cell Communication; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Female; Humans; Inflammation Mediators; Male; NF-kappa B; Ovariectomy; PPAR gamma; Rats; Rats, Sprague-Dawley; Resveratrol; Stereoisomerism; Stilbenes; Up-Regulation | 2010 |
Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Desoxycorticosterone; Fibrosis; Heart; Heart Ventricles; Humans; Hypertension; Male; Mineralocorticoids; Rats; Rats, Wistar; Resveratrol; Sodium Chloride, Dietary; Stilbenes; Ventricular Remodeling | 2011 |
Resveratrol for a longer life--if you're a yeast. The cardiovascular promise of this red wine compound has not been confirmed in humans.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Cardiovascular System; Health Knowledge, Attitudes, Practice; Humans; Resveratrol; Saccharomyces cerevisiae; Stilbenes | 2010 |
Protective effects of resveratrol on calcium-induced oxidative stress in rat heart mitochondria.
Topics: Animals; Antioxidants; Ascorbic Acid; Calcium; Cardiovascular Diseases; Glutathione; Iron; Male; Mitochondria, Heart; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2011 |
Repeated and long-term treatment with physiological concentrations of resveratrol promotes NO production in vascular endothelial cells.
Topics: Antioxidants; Cardiovascular Diseases; Cells, Cultured; Endothelium, Vascular; Enzyme Induction; Enzyme Inhibitors; Estrogen Antagonists; Human Umbilical Vein Endothelial Cells; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Osmolar Concentration; Phosphorylation; PPAR alpha; Protein Processing, Post-Translational; Resveratrol; RNA, Messenger; Stilbenes; Time Factors; Up-Regulation; Wine | 2012 |
Aronia melanocarpa extract suppresses the biotoxicity of homocysteine and its metabolite on the hemostatic activity of fibrinogen and plasma.
Topics: Adult; Anticoagulants; Antioxidants; Blood Coagulation; Cardiovascular Diseases; Coagulants; Dietary Supplements; Fibrinogen; Fruit; Homocysteine; Humans; Hyperhomocysteinemia; Models, Biological; Oxidative Stress; Photinia; Plant Extracts; Poland; Polymerization; Resveratrol; Stilbenes | 2012 |
Plant polyphenols in prevention of heart disease.
Topics: 4-Butyrolactone; Anti-Inflammatory Agents; Antioxidants; Cardiovascular Diseases; Curcumin; Diet, Mediterranean; Humans; Lignans; Plants; Polyphenols; Resveratrol; Stilbenes | 2012 |
Interventions: Live long and prosper.
Topics: Age of Onset; Aging; Animal Diseases; Animals; Biomedical Research; Caloric Restriction; Cardiovascular Diseases; Female; Gene Expression Profiling; Geriatrics; Humans; Longevity; Macaca mulatta; Male; Mice; Models, Animal; Neoplasms; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Resveratrol; Sirolimus; Sirtuins; Somatomedins; Stilbenes; TOR Serine-Threonine Kinases | 2012 |
Resveratrol and non-ethanolic components of wine in experimental cardiology.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Humans; Resveratrol; Stilbenes; Wine | 2003 |
Solid phase extraction of trans-resveratrol from wines for HPLC analysis.
Topics: Cardiovascular Diseases; Chromatography, High Pressure Liquid; Humans; Italy; Resveratrol; Spectrophotometry, Ultraviolet; Stilbenes; Wine | 1993 |
Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone.
Topics: Cardiovascular Diseases; Chromatography, High Pressure Liquid; Desiccation; Fruit; Mitosporic Fungi; Plant Diseases; Reproducibility of Results; Resveratrol; Stilbenes; Wine | 1996 |
Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor.
Topics: Breast Neoplasms; Cardiovascular Diseases; Cell Division; Estradiol; Estrogens, Non-Steroidal; Female; Genes, Reporter; Humans; Isoflavones; Organ Specificity; Phytoestrogens; Plant Preparations; Receptors, Estrogen; Resveratrol; Rosales; Stilbenes; Transcriptional Activation; Tumor Cells, Cultured; Wine | 1997 |